Related Experiment Video
Updated: Jul 26, 2025

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
The role of alternative splicing in lung cancer
Xuelian Ning1, Zitong Fu1, Jing Zhang2
1Department of Pathology, Harbin Medical University, No.157 Baojian Road, Nangang District, Harbin, 150081, China.
Abstract:
Aberrant alternative splicing (AS) events are frequently observed in lung cancer, which can be attributed to aberrant gene AS, alterations in splicing regulatory factors, or changes in splicing regulatory mechanisms. Consequently, the dysregulation of alternative RNA splicing is the fundamental cause of lung cancer. In this review, we have summarized the pivotal role of AS in the development, progression, invasion, metastasis, angiogenesis, and drug resistance of lung cancer. Ultimately, this review emphasizes the potential of AS as biomarkers in lung cancer prognosis and diagnosis, and introduces some applications of AS isoform in the treatment of lung cancer. The comprehension of the AS may provide a glimmer of hope for the eradication of lung cancer.
Insights
Aberrant alternative splicing (AS) is a fundamental cause of lung cancer, driving its development and progression. Understanding AS offers potential for novel diagnostic biomarkers and therapeutic strategies for lung cancer eradication.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Aberrant alternative splicing (AS) events are common in lung cancer.
- These events stem from gene AS, altered splicing factors, or modified regulatory mechanisms.
- Dysregulation of alternative RNA splicing is a root cause of lung cancer.
Purpose of the Study:
- To review the critical role of AS in lung cancer.
- To highlight AS's involvement in cancer development, progression, invasion, metastasis, angiogenesis, and drug resistance.
- To emphasize AS's potential as diagnostic and prognostic biomarkers and its therapeutic applications.
Main Methods:
- Literature review of alternative splicing in lung cancer.
- Synthesis of current research on AS mechanisms and implications.
- Analysis of AS isoforms in diagnosis, prognosis, and treatment.
Main Results:
- AS plays a pivotal role in multiple stages of lung cancer, including development, invasion, and metastasis.
- AS significantly influences angiogenesis and drug resistance in lung cancer.
- AS isoforms show promise as biomarkers for lung cancer prognosis and diagnosis.
Conclusions:
- Understanding alternative splicing is crucial for comprehending lung cancer.
- AS isoforms represent potential therapeutic targets and diagnostic/prognostic tools.
- Further research into AS may lead to effective lung cancer eradication strategies.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
What is Gene Expression?
Pre-mRNA Processing: RNA Splicing
lncRNA - Long Non-coding RNAs

